MedTrace Logo

Relationship Between Prenatal Maternal Distress and the Quality of General Movements at 3 Months

NCT05694676 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-12-08

No results posted yet for this study

Summary

Depression and anxiety symptoms are common during pregnancy which may disturb the intrauterine environment by affecting the mother's physiological responses to stress, and ultimately impair fetal and postnatal development. There is increasing evidence about the effects of maternal distress on young brain tissue leading to some structural changes. The neurological footprints of these structural changes on the young brain may be caught early in life by a video assessment of General Movements (GMs) quality.

Conditions

  • Cerebral Palsy
  • Infant Development
  • Maternal Distress

Interventions

OTHER

Assessment of the quality of Genaral Movements (GMs)

The variation, complexity and fluency of movements over a video recording is done and the quality of GMs is classified as normal-optimal, normal-suboptimal, mildly abnormal, and definitely abnormal movements.

OTHER

State-Trait Anxiety Inventory-Trait, (STAI-T)

The scale consists of 20 items in total and provides a four-point Likert type measurement (1- anxiety symptom is not present, 4- the symptom lasts all the time). Scores range from 20 (low anxiety) to 80 (high anxiety).

OTHER

Beck Depression Inventory, (BDI)

BDI contains 21 items and rates the depressive symptoms for the last week. Each item has four options and is scored between 0 and 3. The total score ranges from 0 to 63. Higher scores indicate more severe depression

Sponsors & Collaborators

  • Karaman Training and Research Hospital

    collaborator OTHER

  • Karamanoğlu Mehmetbey University

    lead OTHER

Principal Investigators

  • Aynur Basaran, MD,Prof · Karaman Training and Research Hospital

Eligibility

Min Age
10 Weeks
Max Age
20 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-17
Primary Completion
2023-10-11
Completion
2023-10-11

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05694676 on ClinicalTrials.gov